The fragile X proteins’ enigma: to be or not to be nucleolar - Archive ouverte HAL
Article Dans Une Revue Frontiers in Cell and Developmental Biology Année : 2024

The fragile X proteins’ enigma: to be or not to be nucleolar

Edouard W Khandjian
  • Fonction : Auteur
  • PersonId : 1424291
Tom Moss
  • Fonction : Auteur
Timothy M Rose
  • Fonction : Auteur
Claude Robert
  • Fonction : Auteur

Résumé

The context

The Fragile X Messenger Ribonucleoprotein (FMRP, previously referred to as Fragile Mental Retardation Protein, see comments in Khandjian et al. ( 2022) is an RNA-binding protein whose mutations or absence cause Fragile X Syndrome (FXS). FMRP is mainly found in the cytoplasm and has been implicated in translation regulation. It has also been suggested to be present in the nucleolus and have a function in ribosome biogenesis. Here we wish to critically survey the data supporting this potentially important secondary function.

FMRP is the archetype of a family of cytoplasmic RNA-binding proteins that includes the Fragile X related proteins FXR1P and FXR2P. The primary transcripts of the FMR1 and FXR1, genes undergo alternative splicing processes (Ashley et al., 1993; Verkerk et al., 1993; Sittler et al., 1996; Kirkpatrick et al., 1999), resulting in multiple protein isoforms. Twelve FMRP isoforms have been detected, nine for FXR1P and one for FXR2P. Members of the Fragile X protein family are widely expressed in human tissues and in other mammals, albeit at varying levels, and expression of their isoforms is subtly choreographed (Davidovic et al., 2006a). FMRP is highly abundant in brain and testis but is absent in striated muscles. FXR1P is strongly expressed in striated muscle and testis and lower levels are detected in the brain. FXR2P expression remains almost constant in all organs and tissues. While the FMR1 gene is present on chromosome X, FXR1 and FXR2 are autosomal genes present on chromosome 12 and 17, respectively.

In humans, mutations in the FMR1 gene are the cause of FXS, a neurodevelopmental disorder that is characterized by development delay, intellectual disability, and in some cases autism spectrum disorders. FXS clinical presentation is highly heterogenous. FXS also affects peripheral tissues with patients exhibiting large everted ears, long face, increased cranial circumference, hypotonia, hyperlaxity of ligaments and macroorchidism (Hagerman et al., 2017). The most prevailing hypothesis regarding the physiopathology of FXS is that the absence of functional FMRP causes dysregulation of translation (Bassell and Warren,

Fichier principal
Vignette du fichier
Khandjian 2024 Frontiers Opinion.pdf (751.29 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04728460 , version 1 (09-10-2024)

Identifiants

Citer

Edouard W Khandjian, Tom Moss, Timothy M Rose, Claude Robert, Laetitia Davidovic. The fragile X proteins’ enigma: to be or not to be nucleolar. Frontiers in Cell and Developmental Biology, 2024, 12, ⟨10.3389/fcell.2024.1448209⟩. ⟨hal-04728460⟩

Altmetric

Partager

More